Details for New Drug Application (NDA): 086363
✉ Email this page to a colleague
NDA 086363 describes THEOLAIR-SR, which is a drug marketed by 3M and is included in four NDAs. Additional details are available on the THEOLAIR-SR profile page.
The generic ingredient in THEOLAIR-SR is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
The generic ingredient in THEOLAIR-SR is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
Summary for 086363
| Tradename: | THEOLAIR-SR |
| Applicant: | 3m |
| Ingredient: | theophylline |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 086363
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 250MG | ||||
| Approval Date: | Jul 16, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
